The Stamford, Connecticut-based company has been accused by nearly every U.S. state of downplaying how dangerously addictive its blockbuster pain killer is while exaggerating its benefits. Prosecutors say the company's marketing practices encouraged doctors to push higher doses of the narcotic and contributed to a public health crisis that claims an average of 130 lives a day.
Inkampani i-Stamford yase-Connecticut ibekwe icala cishe yizo zonke izifundazwe zaseMelika ngokwenza sengathi ayikho inkinga entweni yabo yokuqeda izinhlungu enobuthi obukungenayo ngenkathi yenza ihaba lokuthi kuzuzekani ekuyisebenziseni. Abashushisi bathi izindlela zokuzikhangisa kwenkampani zikhuthaza odokotela ukuthi bandise isilinganiso, bese bedlebelekisa ubucayi kwezempilo okuthatha izimpilo ezili-130 ngosuku.